Concordance evaluation of coronary risk scores: implications for cardiovascular risk screening

References

• Yusuf S. The global problem of cardiovascular disease. Int J Clin Pract Suppl 1998;94:3–6
   PubMedGoogle Scholar
• Reynolds TM, Twomey P, Wierzbicki AS. Accuracy of cardiovascular risk estimation in patients without diabetes. J Cardiovasc Risk 2002;9:183–90
   Google Scholar
• Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991;121:293–8
   PubMed Web of Science ®Google Scholar
• Wierzbicki AS, Reynolds TM, Gill K, Alg S, Crook MA. A comparison of algorithms for initiation of lipid lowering therapy in primary prevention of coronary heart disease. J Cardiovasc Risk 2000;7:63–71
   Google Scholar
• Haq IU, Jackson PR, Yeo WW, Ramsay LE. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet 1995;346:1467–71
   PubMed Web of Science ®Google Scholar
• Ramsay LE, Haq IU, Jackson PR, Yeo WW, Pickin DM, Payne JN. Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table. Lancet 1996;348:387–8
   PubMed Web of Science ®Google Scholar
• Primatesta P, Poulter NR. Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey. Br Med J 2000;321:1322–5
   PubMed Web of Science ®Google Scholar
• Yates FE, Benton LA. Blood pressure levels and variance assessed by ambulatory monitoring: optimal parameters. Ann Biomed Eng 1990;18:377–405
   PubMed Web of Science ®Google Scholar
• Stanforth PR, Gagnon J, Rice T, et al. Reproducibility of resting blood pressure and heart rate measurements. The HERITAGE Family Study. Ann Epidemiol 2000;10:271–7
   PubMed Web of Science ®Google Scholar
• Primatesta P, Brookes M, Poulter NR. Improved hypertension management and control: results from the health survey for England 1998. Hypertension 2001;38: 827–32
   Google Scholar
• Verdecchia P, Schillaci G, Reboldi G, Franklin SS, Porcellati C. Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation 2001;103: 2579–84
   Google Scholar
• Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002;105: 310–5
   Google Scholar
• Little P, Barnett J, Barnsley L, Marjoram J, Fitzgerald-Barron A, Mant D. Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure. Br Med J 2002;325:254
   Google Scholar
• British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998;80 (Suppl 2):S1–29
   Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report of The National Cholesterol Education Program (NCEP). J Am Med Assoc 2001;285:2486–97
   Google Scholar
• Odell PM, Anderson KM, Kannel WB. New models for predicting cardiovascular events. J Clin Epidemiol 1994;47: 583–92
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report of The National Cholesterol Education Program (NCEP). J Am Med Assoc 2001;285:2486–97
   Google Scholar
• British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998;80 (Suppl 2):S1–29
   Google Scholar
• Liao Y, McGee DL, Cooper RS, Sutkowski MB. How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts. Am Heart J 1999;137:837–45
   PubMed Web of Science ®Google Scholar
• Wallis EJ, Ramsay LE, Ul Haq I, et al. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population. Br Med J 2000;320:671–6
   PubMed Web of Science ®Google Scholar
• Rabindranath KS, Anderson NR, Gama R, Holland MR. Comparative evaluation of the new Sheffield table and the modified joint British societies coronary risk prediction chart against a laboratory based risk score calculation. Postgrad Med J 2002;78:269–72
   PubMed Web of Science ®Google Scholar
• Haq IU, Ramsay LE, Yeo WW, Jackson PR, Wallis EJ. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart 1999;81:40–6
   Google Scholar
• Bastuji-Garin S, Deverly A, Moyse D, et al. The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertens 2002;20:1973–80
   Google Scholar
• Thomsen TF, McGee D, Davidsen M, Jorgensen T. A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 2002;31:817–22
   PubMed Web of Science ®Google Scholar
• Empana JP, Ducimetiere P, Arveiler D, et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 2003;24:1903–11
   PubMed Web of Science ®Google Scholar
• Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000;21:365–70
   Google Scholar
• D’Agostino Sr. RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. J Am Med Assoc 2001;286:180–7
   Web of Science ®Google Scholar
• Orford JL, Sesso HD, Stedman M, Gagnon D, Vokonas P, Gaziano JM. A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study. Am Heart J 2002;144:95–100
   PubMed Web of Science ®Google Scholar
• Hense HW, Schulte H, Lowel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany – results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003;24:937–45
   Google Scholar
• Voss R, Cullen P, Schulte H, Assmann G. Prediction of risk of coronary events in middle-aged men in the Prospective Cardiovascular Munster Study (PROCAM) using neural networks. Int J Epidemiol 2002;31:1253–62
   PubMed Web of Science ®Google Scholar
• Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003
   PubMed Web of Science ®Google Scholar